This site is intended for Healthcare professionals only.
×

JnJ to submit applications for at least 10 new drugs by 2023


JnJ to submit applications for at least 10 new drugs by 2023

This is part of the healthcare conglomerate’s plan to deliver above-market growth through 2023 at its Janssen unit, JnJ said.

New Delhi: Johnson & Johnson said on Wednesday it expected to file marketing applications for at least 10 new drugs between 2019 to 2023, to strengthen its pharmaceuticals unit which has been a major growth driver.

This is part of the healthcare conglomerate’s plan to deliver above-market growth through 2023 at its Janssen unit, it said. The plan comes ahead of J&J’s business review, scheduled later on Wednesday.

Also Read: JnJ baby shampoo free from carcinogenic Formaldehyde; says Gujarat FDCA

The company said it would discuss four medicines that are new to J&J’s pipeline of drugs at its review as well as therapeutic areas such as gene therapy and RNA therapeutics.

Also Read: JnJ baby shampoo on attack; gets BANNED in Uttar Pradesh



Source: Reuters
0 comment(s) on JnJ to submit applications for at least 10 new drugs by 2023

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted